Suppr超能文献

免疫接种的变革:mRNA疫苗技术与应用的全面综述

Revolutionizing immunization: a comprehensive review of mRNA vaccine technology and applications.

作者信息

Leong Kai Yuan, Tham Seng Kong, Poh Chit Laa

机构信息

MyGenome, ALPS Global Holding Berhad, Kuala Lumpur, Malaysia.

出版信息

Virol J. 2025 Mar 12;22(1):71. doi: 10.1186/s12985-025-02645-6.

Abstract

Messenger RNA (mRNA) vaccines have emerged as a transformative platform in modern vaccinology. mRNA vaccine is a powerful alternative to traditional vaccines due to their high potency, safety, and efficacy, coupled with the ability for rapid clinical development, scalability and cost-effectiveness in manufacturing. Initially conceptualized in the 1970s, the first study about the effectiveness of a mRNA vaccine against influenza was conducted in 1993. Since then, the development of mRNA vaccines has rapidly gained significance, especially in combating the COVID-19 pandemic. Their unprecedented success during the COVID-19 pandemic, as demonstrated by the Pfizer-BioNTech and Moderna vaccines, highlighted their transformative potential. This review provides a comprehensive analysis of the mRNA vaccine technology, detailing the structure of the mRNA vaccine and its mechanism of action in inducing immunity. Advancements in nanotechnology, particularly lipid nanoparticles (LNPs) as delivery vehicles, have revolutionized the field. The manufacturing processes, including upstream production, downstream purification, and formulation are also reviewed. The clinical progress of mRNA vaccines targeting viruses causing infectious diseases is discussed, emphasizing their versatility and therapeutic potential. Despite their success, the mRNA vaccine platform faces several challenges, including improved stability to reduce dependence on cold chain logistics in transport, enhanced delivery mechanisms to target specific tissues or cells, and addressing the risk of rare adverse events. High costs associated with encapsulation in LNPs and the potential for unequal global access further complicate their widespread adoption. As the world continues to confront emerging viral threats, overcoming these challenges will be essential to fully harness the potential of mRNA vaccines. It is anticipated that mRNA vaccines will play a major role in defining and shaping the future of global health.

摘要

信使核糖核酸(mRNA)疫苗已成为现代疫苗学中一个具有变革性的平台。mRNA疫苗因其高效力、安全性和有效性,以及快速临床开发、可扩展性和生产成本效益的能力,成为传统疫苗的有力替代品。mRNA疫苗最初在20世纪70年代被提出概念,1993年进行了第一项关于mRNA疫苗抗流感有效性的研究。从那时起,mRNA疫苗的开发迅速变得重要起来,尤其是在抗击新冠疫情方面。辉瑞- BioNTech和莫德纳疫苗所展示的,它们在新冠疫情期间取得的前所未有的成功,凸显了其变革潜力。本综述对mRNA疫苗技术进行了全面分析,详细介绍了mRNA疫苗的结构及其诱导免疫的作用机制。纳米技术的进步,特别是脂质纳米颗粒(LNPs)作为递送载体,彻底改变了这一领域。还综述了制造工艺,包括上游生产、下游纯化和制剂。讨论了针对引起传染病的病毒的mRNA疫苗的临床进展,强调了它们的多功能性和治疗潜力。尽管取得了成功,但mRNA疫苗平台仍面临若干挑战,包括提高稳定性以减少运输中对冷链物流的依赖、增强靶向特定组织或细胞的递送机制,以及应对罕见不良事件的风险。与封装在LNPs中的高成本以及全球获取不平等的可能性进一步使它们的广泛应用复杂化。随着世界继续面对新出现的病毒威胁,克服这些挑战对于充分发挥mRNA疫苗的潜力至关重要。预计mRNA疫苗将在定义和塑造全球健康的未来方面发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/11900334/9c3beb60d82c/12985_2025_2645_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验